
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol’s native token.

The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol’s native token.
Ultricies augue id venenatis at egestas aenean semper ac lectus praesent consequat.